Related references
Note: Only part of the references are listed.Biochemical Correction of X-CGD by a Novel Chimeric Promoter Regulating High Levels of Transgene Expression in Myeloid Cells
Giorgia Santilli et al.
MOLECULAR THERAPY (2011)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein et al.
NATURE MEDICINE (2010)
Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
Ute Modlich et al.
MOLECULAR THERAPY (2009)
Cell-intrinsic and Vector-related Properties Cooperate to Determine the Incidence and Consequences of Insertional Mutagenesis
Olga S. Kustikova et al.
MOLECULAR THERAPY (2009)
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Nathalie Cartier et al.
SCIENCE (2009)
Resistance of mature T cells to oncogene transformation
Sebastian Newrzela et al.
BLOOD (2008)
Genotypic features of lentivirus transgenic mice
Marc-Olivier Sauvain et al.
JOURNAL OF VIROLOGY (2008)
Insertional mutagenesis in gene therapy and stem cell biology
Christopher Baum
CURRENT OPINION IN HEMATOLOGY (2007)
Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients
S. Charrier et al.
GENE THERAPY (2007)
Development of a synthetic promoter for macrophage gene therapy
Weijing He et al.
HUMAN GENE THERAPY (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
A lentiviral vector encoding the human Wiskott Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice
S Charrier et al.
GENE THERAPY (2005)
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences
RS Mitchell et al.
PLOS BIOLOGY (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator
A Ramezani et al.
BLOOD (2003)
Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo
T VandenDriessche et al.
BLOOD (2002)
Expression pattern of a mini human PrP gene promoter in transgenic mice
EA Asante et al.
NEUROBIOLOGY OF DISEASE (2002)
Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities
F Recillas-Targa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter
C Demaison et al.
HUMAN GENE THERAPY (2002)
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors
C Lois et al.
SCIENCE (2002)
Chronic granulomatous disease - Report on a national registry of 368 patients
JA Winkelstein et al.
MEDICINE (2000)
A conserved domain of the arabidopsis GNOM protein mediates subunit interaction and cyclophilin 5 binding
M Grebe et al.
PLANT CELL (2000)
Share Paper
